Detalhe da pesquisa
1.
Primary mucinous carcinomas of the skin express TFF1, TFF3, estrogen receptor, and progesterone receptors.
Am J Surg Pathol
; 22(9): 1125-31, 1998 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-9737246
2.
Amphiregulin and cripto overexpression in breast-cancer - relationship with prognosis and clinical and molecular-variables.
Int J Oncol
; 7(3): 617-22, 1995 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21552881
3.
Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis?
Hum Pathol
; 24(5): 469-76, 1993 May.
Artigo
Inglês
| MEDLINE | ID: mdl-7684021
4.
Angiogenesis and expression of thymidine phosphorylase by inflammatory and carcinoma cells in ductal carcinoma in situ of the breast.
J Pathol
; 187(3): 285-90, 1999 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-10398080
5.
Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Anal Cell Pathol
; 9(1): 45-52, 1995 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-7577754
6.
Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma. Fibroblastic expression has strong associations with tumor pathology.
Am J Pathol
; 157(4): 1219-27, 2000 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-11021826
7.
Minimal breast cancer: evaluation of histology and biological marker expression.
Br J Cancer
; 80(10): 1608-16, 1999 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-10408407
8.
Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
J Pathol
; 185(4): 394-401, 1998 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-9828838
9.
p53 immunohistochemical staining and survival after adjuvant chemotherapy for breast cancer.
Int J Cancer
; 74(6): 605-8, 1997 Dec 19.
Artigo
Inglês
| MEDLINE | ID: mdl-9421356
10.
Aberrant expression of p53 tumour-suppressor protein in non-melanoma skin cancer.
Br J Dermatol
; 127(5): 463-9, 1992 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-1467284
11.
p53 immunoreactivity in human malignant melanoma and dysplastic naevi.
Br J Dermatol
; 128(6): 606-11, 1993 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-8338744
12.
TGF alpha and TGF beta expression in mammary carcinoma.
J Pathol
; 170(1): 15-22, 1993 May.
Artigo
Inglês
| MEDLINE | ID: mdl-8392105
13.
p53 immunoreactivity is uncommon in primary cutaneous lymphoma.
Br J Dermatol
; 132(3): 353-8, 1995 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-7718450
14.
Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
Am J Pathol
; 152(3): 721-8, 1998 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-9502414
15.
Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parameters.
Int J Cancer
; 79(1): 71-5, 1998 Feb 20.
Artigo
Inglês
| MEDLINE | ID: mdl-9495362
16.
Expression of the ERBB3 gene product in breast cancer.
Br J Cancer
; 66(6): 1116-21, 1992 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-1333787
17.
Posttransplant skin cancer: a possible role for p53 gene mutation but not for oncogenic human papillomaviruses.
J Am Acad Dermatol
; 30(5 Pt 1): 701-6, 1994 May.
Artigo
Inglês
| MEDLINE | ID: mdl-8176007
18.
BAG-i expression in human breast cancer: interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data.
J Pathol
; 197(1): 51-9, 2002 May.
Artigo
Inglês
| MEDLINE | ID: mdl-12081204